Home›People›Jean-Francois Formela
JF

Jean-Francois Formela

Director at Antares Therapeutics. Also a director at Scorpion Therapeutics.

DirectorRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing May 15, 2025·Suggest an edit

About Jean-Francois Formela

Jean-Francois Formela is a director at Antares Therapeutics.

Form D filings also name Jean-Francois Formela as a director at Scorpion Therapeutics.

Jean-Francois Formela first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Jean-Francois Formela in the role, so the role may have started earlier or lasted longer.

Antares Therapeutics, Inc.
Director
2025 · Boston, MA
Scorpion Therapeutics, Inc.
Director
2020 – 2024 · Boston, MA

Key Colleagues at Startups

The people Jean-Francois Formela works with at each company, as listed on that company's latest Form D.

Antares Therapeutics, Inc. · Form D, May 15, 2025
AF
Andrew Fedder
General Counsel
JA
KF
AF
Adam Friedman
Executive officer and director
BP
Brian Piper
Executive officer
SC
Shelley Chu
Director
Scorpion Therapeutics, Inc. · Form D, Jul 16, 2024
AF
Andrew Fedder
Executive officer
ON
AF
Adam Friedman
Chief Executive Officer and director
SC
Shelley Chu
Director
DS
Darrin Stuart
Executive officer
EJ
Erica Jackson
Executive officer
AV
Amanda Valentino
Executive officer
JA
SS
Saurabh Saha
Director
AG
Arjun Goyal
Director
KF
MC
Mark Chao
Executive officer
BP
Brian Piper
Executive officer

Sources

  1. SECAntares Therapeutics, Inc. Form D, filed May 15, 2025
  2. SECScorpion Therapeutics, Inc. Form D, filed Jul 16, 2024